Kraiczy P - Search Results

1

Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi.

Hunfeld KP, Wichelhaus TA, Rödel R, Acker G, Brade V, Kraiczy P. Hunfeld KP, et al. Among authors: kraiczy p. Antimicrob Agents Chemother. 2004 Jan;48(1):344-7. doi: 10.1128/AAC.48.1.344-347.2004. Antimicrob Agents Chemother. 2004. PMID: 14693564 Free PMC article.

2

3D blood-brain barrier-organoids as a model for Lyme neuroborreliosis highlighting genospecies dependent organotropism.

Adams Y, Clausen AS, Jensen PØ, Lager M, Wilhelmsson P, Henningson AJ, Lindgren PE, Faurholt-Jepsen D, Mens H, Kraiczy P, Kragh KN, Bjarnsholt T, Kjaer A, Lebech AM, Jensen AR. Adams Y, et al. Among authors: kraiczy p. iScience. 2022 Dec 19;26(1):105838. doi: 10.1016/j.isci.2022.105838. eCollection 2023 Jan 20. iScience. 2022. PMID: 36686395 Free PMC article.

3

Growth inhibitory and bactericidal efficacy of sera from Lyme borreliosis patients on B. burgdorferi strains.

Kraiczy P, Peters S, Seitz C, Würzner R, Oschmann P, Brade V. Kraiczy P, et al. Wien Klin Wochenschr. 1998 Dec 23;110(24):886-93. Wien Klin Wochenschr. 1998. PMID: 10048171

4

Serologic evidence for tick-borne pathogens other than Borrelia burgdorferi (TOBB) in Lyme borreliosis patients from midwestern Germany.

Hunfeld KP, Allwinn R, Peters S, Kraiczy P, Brade V. Hunfeld KP, et al. Among authors: kraiczy p. Wien Klin Wochenschr. 1998 Dec 23;110(24):901-8. Wien Klin Wochenschr. 1998. PMID: 10048174

5

New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances.

Hunfeld KP, Kraiczy P, Wichelhaus TA, Schäfer V, Brade V. Hunfeld KP, et al. Among authors: kraiczy p. Eur J Clin Microbiol Infect Dis. 2000 Jan;19(1):27-32. doi: 10.1007/s100960050005. Eur J Clin Microbiol Infect Dis. 2000. PMID: 10706176

6

Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi isolates.

Kraiczy P, Hunfeld KP, Breitner-Ruddock S, Würzner R, Acker G, Brade V. Kraiczy P, et al. Immunobiology. 2000 Jan;201(3-4):406-19. doi: 10.1016/S0171-2985(00)80094-7. Immunobiology. 2000. PMID: 10776796

7

Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates.

Hunfeld KP, Kraiczy P, Wichelhaus TA, Schäfer V, Brade V. Hunfeld KP, et al. Among authors: kraiczy p. Int J Antimicrob Agents. 2000 Jun;15(1):11-7. doi: 10.1016/s0924-8579(00)00116-3. Int J Antimicrob Agents. 2000. PMID: 10856671

8

Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant.

Kraiczy P, Hunfeld KP, Peters S, Würzner R, Acker G, Wilske B, Brade V. Kraiczy P, et al. J Med Microbiol. 2000 Oct;49(10):917-928. doi: 10.1099/0022-1317-49-10-917. J Med Microbiol. 2000. PMID: 11023189

9

In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi.

Hunfeld KP, Weigand J, Wichelhaus TA, Kekoukh E, Kraiczy P, Brade V. Hunfeld KP, et al. Among authors: kraiczy p. Int J Antimicrob Agents. 2001 Mar;17(3):203-8. doi: 10.1016/s0924-8579(00)00342-3. Int J Antimicrob Agents. 2001. PMID: 11282265

10

Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates.

Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V. Kraiczy P, et al. Int Immunopharmacol. 2001 Mar;1(3):393-401. doi: 10.1016/s1567-5769(00)00041-2. Int Immunopharmacol. 2001. PMID: 11367524 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters